Novartis AG (NVS) Financials

NVS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 99.9 billion 53.2 billion
2023-09-30 112.7 billion 74.5 billion
2023-06-30 111.0 billion 59.0 billion
2023-03-31 112.2 billion 60.1 billion

NVS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 1.8 billion 248.0 million
2023-09-30 4.7 billion 205.0 million
2023-06-30 2.6 billion 233.0 million
2023-03-31 2.5 billion 199.0 million

NVS Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 2.6 billion
2023-09-30 1.5 billion
2023-06-30 2.3 billion
2023-03-31 2.3 billion

NVS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 14.0 billion - 1.8 billion
2023-09-30 12.7 billion 19.5 billion 1.7 billion
2023-06-30 11.2 billion 19.8 billion 1.8 billion
2023-03-31 12.3 billion 22.0 billion 1.8 billion

NVS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.1 billion
2023-09-30 2.1 billion
2023-06-30 2.1 billion
2023-03-31 2.1 billion

NVS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 783.0 million 2.6 billion 3.4 billion -
2023-09-30 683.0 million 3.9 billion 3.1 billion -
2023-06-30 996.0 million 2.5 billion 3.7 billion -
2023-03-31 470.0 million 2.8 billion 3.4 billion -

NVS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 11.8 billion 3.0 billion
2023-09-30 12.1 billion 3.1 billion
2023-06-30 13.9 billion 4.3 billion
2023-03-31 13.2 billion 3.9 billion

NVS

List: Challengers

Price: $97.44

52 week price:
85.59
108.78

Dividend Yield: 3.84%

5-year range yield:
3.58%
4.19%

Forward Dividend Yield: 3.88%

Payout Ratio: 92.13%

Payout Ratio Range:
25.57%
271.61%

Dividend Per Share: 3.78 USD

Earnings Per Share: 4.10 USD

P/E Ratio: 24.72

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 1.7 million

Ebitda: 2.5 billion

Market Capitalization: 200.7 billion

Average Dividend Frequency: 1

Years Paying Dividends: 28

DGR3: 4.59%

DGR5: 5.70%

DGR10: 4.54%

DGR20: 9.41%

Links: